ALN-BCAT
ALN-BCAT-001
Phase 1 small_molecule active
Quick answer
ALN-BCAT for Advanced Hepatocellular Carcinoma is a Phase 1 program (small_molecule) at Alnylam Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alnylam Netherlands B.V.
- Indication
- Advanced Hepatocellular Carcinoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active